Mathilda Mandel

1.9k total citations · 1 hit paper
53 papers, 1.3k citations indexed

About

Mathilda Mandel is a scholar working on Infectious Diseases, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mathilda Mandel has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Molecular Biology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Mathilda Mandel's work include SARS-CoV-2 and COVID-19 Research (12 papers), Multiple Sclerosis Research Studies (11 papers) and COVID-19 Clinical Research Studies (8 papers). Mathilda Mandel is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Multiple Sclerosis Research Studies (11 papers) and COVID-19 Clinical Research Studies (8 papers). Mathilda Mandel collaborates with scholars based in Israel, United States and Poland. Mathilda Mandel's co-authors include Anat Achiron, Michael Gurevich, Gad Lavie, Sapir Dreyer-Alster, Polina Sonis, David Magalashvili, Shlomo Flechter, Mark Dolev, Shay Menascu and Rina Falb and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Mathilda Mandel

51 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

2021 235 citations Anat Achiron, Mathilda Mandel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathilda Mandel Israel	20	396	389	360	246	231	53	1.3k
Antonio Angeloni Italy	28	230 0.6×	414 1.1×	541 1.5×	186 0.8×	120 0.5×	149	2.2k
M. Tarek Elghetany United States	22	140 0.4×	313 0.8×	382 1.1×	448 1.8×	166 0.7×	73	1.7k
Suat‐Cheng Peh Malaysia	17	313 0.8×	337 0.9×	309 0.9×	314 1.3×	110 0.5×	41	1.6k
Suzanne Bruce United States	28	251 0.6×	173 0.4×	119 0.3×	272 1.1×	189 0.8×	79	2.2k
Farhan Cyprian Qatar	18	140 0.4×	266 0.7×	353 1.0×	340 1.4×	112 0.5×	42	1.3k
Tomasz Wróbel Poland	22	498 1.3×	156 0.4×	560 1.6×	434 1.8×	96 0.4×	198	1.9k
John A. Goss United States	25	172 0.4×	180 0.5×	574 1.6×	149 0.6×	37 0.2×	79	2.8k
Sanjay S. Patel United States	20	153 0.4×	114 0.3×	285 0.8×	251 1.0×	51 0.2×	60	1.6k
Giovanni Carulli Italy	18	314 0.8×	163 0.4×	277 0.8×	309 1.3×	39 0.2×	121	1.4k

Countries citing papers authored by Mathilda Mandel

Since Specialization

Citations

This map shows the geographic impact of Mathilda Mandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilda Mandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilda Mandel more than expected).

Fields of papers citing papers by Mathilda Mandel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilda Mandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilda Mandel. The network helps show where Mathilda Mandel may publish in the future.

Co-authorship network of co-authors of Mathilda Mandel

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilda Mandel. A scholar is included among the top collaborators of Mathilda Mandel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilda Mandel. Mathilda Mandel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Achiron, Anat, Rina Falb, Shay Menascu, et al.. (2024). Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation. Neurobiology of Disease. 194. 106475–106475.

Menascu, Shay, Sapir Dreyer-Alster, David Magalashvili, et al.. (2023). Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(1). 3090514327–3090514327. 4 indexed citations

Magalashvili, David, Mathilda Mandel, Sapir Dreyer-Alster, et al.. (2022). Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4. Journal of Neuroimmunology. 372. 577966–577966. 15 indexed citations

Dreyer-Alster, Sapir, Shay Menascu, Mathilda Mandel, et al.. (2022). COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose. Journal of the Neurological Sciences. 434. 120155–120155. 40 indexed citations

Achiron, Anat, Michael Gurevich, Rina Falb, et al.. (2021). SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Clinical Microbiology and Infection. 27(9). 1349.e1–1349.e6. 26 indexed citations

Achiron, Anat, Mathilda Mandel, Sapir Dreyer-Alster, et al.. (2021). Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study. Journal of Neuroimmunology. 361. 577746–577746. 56 indexed citations

Gurevich, Michael, Rina Zilkha‐Falb, Polina Sonis, et al.. (2021). SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients. International Journal of Infectious Diseases. 115. 208–214. 17 indexed citations

Mandel, Mathilda, et al.. (2020). Cytokine prediction of mortality in COVID19 patients. Cytokine. 134. 155190–155190. 49 indexed citations

Zafrir, Yaron, Boris Gilburd, Shaye Kivity, et al.. (2013). Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases. Immunologic Research. 56(2-3). 451–456. 8 indexed citations

10.

Barliya, Tilda, Mathilda Mandel, Tami Livnat, Dov Weinberger, & Gad Lavie. (2011). Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy. PLoS ONE. 6(9). e22849–e22849. 40 indexed citations

11.

Mandel, Mathilda, Michael Gurevich, Gad Lavie, Irun R. Cohen, & Anat Achiron. (2005). Unique Gene Expression Patterns in Human T‐cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide. Journal of Immunology Research. 12(3). 203–209. 7 indexed citations

12.

Lavie, Gad, Mathilda Mandel, Tilda Barliya, et al.. (2005). Anti-Angiogenic Activities of Hypericin in vivo: Potential for Ophthalmologic Applications. Angiogenesis. 8(1). 35–42. 27 indexed citations

13.

Bank, Ilan, et al.. (2002). Interaction of Disease-Related Antigen-Reactive T-Cell Lines from Multiple Sclerosis Patients with Type IV Collagen: Role of Integrin VLA-1 and Effects of Irradiation. Journal of Clinical Immunology. 22(3). 153–163. 10 indexed citations

14.

Lavie, Gad, et al.. (2000). Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases. International Immunology. 12(4). 479–486. 13 indexed citations

15.

Bielorai, Bella, Yoram Neumann, Itamar Avigad, et al.. (2000). Successful treatment of vancomycin-resistantEnterococcus sepsis in a neutropenic patient with G-CSF-mobilized granulocyte transfusions. Medical and Pediatric Oncology. 34(3). 221–223. 4 indexed citations

16.

Sharon, Nehama, Amos Toren, Lea Pollak, et al.. (1997). Desmoplastic Infantile Ganglioglioma. Acta Oncologica. 36(6). 655–657. 11 indexed citations

17.

Mandel, Mathilda, Gideon Rechavi, Yoram Neumann, et al.. (1994). CD10⁺ cell population in the bone marrow of patients with advanced neuroblastoma. Medical and Pediatric Oncology. 22(2). 115–118. 6 indexed citations

18.

Mandel, Mathilda, et al.. (1993). Dna Content—A Prognostic Factor in Childhood Medulloblastoma?. Acta Oncologica. 32(6). 691–692. 1 indexed citations

19.

Toren, Amos, Mathilda Mandel, Ninette Amariglio, et al.. (1991). Lack of bcr rearrangement in juvenile chronic myeloid leukemia. Medical and Pediatric Oncology. 19(6). 493–495. 8 indexed citations

20.

Rechavi, G, Mathilda Mandel, Nurit Katzir, et al.. (1989). Immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukaemia: correlation with clinical stage. British Journal of Haematology. 72(4). 524–529. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact